ApicHope Pharmaceutical Co., Ltd

SZSE:300723 Stock Report

Market Cap: CN¥10.2b

ApicHope Pharmaceutical Future Growth

Future criteria checks 5/6

ApicHope Pharmaceutical is forecast to grow earnings and revenue by 39.1% and 21.8% per annum respectively. EPS is expected to grow by 38.5% per annum. Return on equity is forecast to be 14.2% in 3 years.

Key information

39.1%

Earnings growth rate

38.5%

EPS growth rate

Pharmaceuticals earnings growth18.3%
Revenue growth rate21.8%
Future return on equity14.2%
Analyst coverage

Good

Last updated29 Apr 2024

Recent future growth updates

Recent updates

ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet

Mar 15
ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet

Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings

Feb 27
Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings

Earnings and Revenue Growth Forecasts

SZSE:300723 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,879378N/A6922
12/31/20254,077514N/A7106
12/31/20242,836237N/A6212
3/31/20242,410174135480N/A
12/31/20232,503185124458N/A
9/30/20232,515307119416N/A
6/30/20232,641341123511N/A
3/31/20232,480322-21480N/A
12/31/20222,280291-130476N/A
9/30/20222,161285-153511N/A
6/30/20222,151344-157540N/A
3/31/20222,200319-176455N/A
12/31/20212,199307-123438N/A
9/30/20212,135317-133388N/A
6/30/20211,978263-163279N/A
3/31/20211,851250-63341N/A
12/31/20201,675226-39275N/A
9/30/20201,640173-51201N/A
6/30/20201,51511778249N/A
3/31/20201,64113828144N/A
12/31/20191,637144175281N/A
9/30/20191,537243223301N/A
6/30/20191,435234169275N/A
3/31/20191,39521924297N/A
12/31/20181,430208-18239N/A
9/30/20181,42618023263N/A
6/30/20181,477167-10185N/A
3/31/20181,467166156186N/A
12/31/20171,380157N/A158N/A
9/30/20171,399156N/A109N/A
12/31/20161,251137N/A146N/A
12/31/20151,02860N/A35N/A
12/31/201479340N/A9N/A
12/31/201350833N/A136N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300723's forecast earnings growth (39.1% per year) is above the savings rate (2.9%).

Earnings vs Market: 300723's earnings (39.1% per year) are forecast to grow faster than the CN market (24.3% per year).

High Growth Earnings: 300723's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300723's revenue (21.8% per year) is forecast to grow faster than the CN market (14.6% per year).

High Growth Revenue: 300723's revenue (21.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300723's Return on Equity is forecast to be low in 3 years time (14.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.